The IMARC Group's latest research report, titled “Oral Proteins and Peptides Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032,” offers a comprehensive analysis of the oral proteins and peptides market insights. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry.
The global oral proteins and peptides market size reached US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.3 Billion by 2032, exhibiting a growth rate (CAGR) of 7.51% during 2024-2032.
Oral Proteins and Peptides Market Trends:
The growing prevalence of chronic diseases such as diabetes and cancer are driving the global market. Moreover, the rising awareness among healthcare providers and patients about the benefits of oral administration over injections contributes to market growth. Moreover, the growing elderly population, which requires more manageable medication forms, fuels demand. Furthermore, extensive research and development investments by pharmaceutical companies to develop innovative products propel the market expansion. Additionally, favorable regulatory frameworks and expedited approval processes encourage the introduction of new therapies. The increasing adoption of personalized medicine and tailored treatment regimens based on genetic profiles further augments market growth.
Get Sample Copy of Report at – https://www.imarcgroup.com/oral-proteins-peptides-market/requestsample
Oral Proteins and Peptides Market Scope & Growth Analysis:
The scope of the global market is expanding due to continuous advancements in biotechnology and molecular engineering. Increasing healthcare expenditures and government funding for biopharmaceutical research significantly contribute to the market. The market also benefits from the rising trend of outsourcing drug development and manufacturing processes to specialized contract research and manufacturing organizations, which accelerates product development timelines. Furthermore, the integration of advanced drug delivery systems, such as nanoparticles and microneedles, enhances the efficiency and patient compliance of oral therapies. Expanding global healthcare infrastructure, particularly in emerging economies, provides new opportunities for market penetration. Additionally, strategic mergers and acquisitions among pharmaceutical giants are fostering innovation and expanding product portfolios. The growing focus on sustainable and cost-effective treatment solutions also augments the market, as oral proteins and peptides offer non-invasive, patient-friendly alternatives to traditional therapies. As per market analysis, these factors collectively contribute to the significant growth potential and expansive scope of the oral proteins and peptides market.
Competitive Landscape with Key Players:
- Amryt Pharma Plc
- AstraZeneca PLC
- Biocon Limited
- Novo Nordisk A/S
- Oramed Ltd
- Proxima Concepts Limited
Key Market Segmentation:
Drug Type Insights:
- Linaclotide
- Plecanatide
- Calcitonin
- Insulin
- Octreotide
Application Insights:
- Gastric and Digestive Disorders
- Bone Diseases
- Diabetes
- Hormonal Disorders
Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key Highlights of the Report:
- Market Performance
- Market Outlook
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Who we are:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
